STRS Ohio’s Amylyx Pharmaceuticals AMLX Stock Holding History

STRS Ohio’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$47.3K	Hold	3,400	–	–	﹤0.01%	1945
2025 Q4	$41.1K	Hold	3,400	–	–	﹤0.01%	2019
2025 Q3	$46.2K	Sell	3,400 -3,900	-53%	-$36.7K	﹤0.01%	2019
2025 Q2	$46.8K	Buy	+7,300	New	+$35.5K	﹤0.01%	2033
2024 Q2	–	Sell	-16,500	Closed	-$46K	–	1956
2024 Q1	$46K	Sell	16,500 -1,000	-6%	-$13.1K	﹤0.01%	1772
2023 Q4	$257K	Buy	+17,500	New	+$268K	﹤0.01%	1497
2023 Q2	–	Sell	-12,300	Closed	-$360K	–	1939
2023 Q1	$360K	Buy	12,300 +7,800	+173%	+$271K	﹤0.01%	1453
2022 Q4	$166K	Buy	4,500 +3,300	+275%	+$117K	﹤0.01%	1626
2022 Q3	$33K	Hold	1,200	–	–	﹤0.01%	1882
2022 Q2	$23K	Sell	1,200 -1,100	-48%	-$13.1K	﹤0.01%	1949
2022 Q1	$29K	Buy	+2,300	New	+$51.9K	﹤0.01%	2008

Other funds holding AMLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

STRS Ohio's AMLX Position: Q1 2026 in Review

STRS Ohio held its Amylyx Pharmaceuticals (AMLX) position steady in Q1 2026 at 3,400 shares worth $47.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1945.

STRS Ohio first reported a position in AMLX in Q1 2022 and has held it in 11 quarters since. The position peaked at $360K in Q1 2023. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

STRS Ohio held 3,400 shares of Amylyx Pharmaceuticals worth $47.3K as of Q1 2026.
STRS Ohio left its Amylyx Pharmaceuticals share count unchanged in Q1 2026.
Amylyx Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1945 holding.
STRS Ohio first reported a position in Amylyx Pharmaceuticals in Q1 2022 and has held it in 11 quarters since.
STRS Ohio's Amylyx Pharmaceuticals position peaked at $360K in Q1 2023.
171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.